EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyse

A Systematic Review With Meta‐Analysis of Endogenous Opioid System Biomarkers in Patients With Chronic Axial Pain, Chronic Widespread Pain, and Fibromyalgia

Karin Due Bruun iD, Maria Charlotte Reiersoel Moerkeberg iD, Julie Roenne Pedersen iD, Daniel Broholm iD, Morten Rune Blichfeldt-Eckhardt iD, Lotte Abildgren

European Journal of Pain · 2026

DOI: 10.1002/ejp.70192 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift European Journal of Pain, 2026. Verfasst von Karin Due Bruun und 5 weiteren Autor:innen. Beteiligte Einrichtung: Pain Research Group, Pain Center, Odense University Hospital, Odense, Denmark. Hauptthemen laut MEDLINE: Fibromyalgia, Chronic Pain, Receptors, Opioid, Low Back Pain. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 69 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The opioid system is involved in the regulation of pain as well as stress homeostasis. Stress‐induced opioid dysregulation has been proposed as a mechanism for pain development in patients with fibromyalgia (FM) and chronic low back pain (cLBP). However, the evidence to support this hypothesis is conflicting.

Methods

We conducted a systematic literature search in MEDLINE, EMBASE, and the Cochrane Library database to investigate whether patients with FM or cLBP exhibit (1) different levels of endogenous opioids or anti‐opioids in body fluids or tissue samples, or (2) altered levels of opioid receptor expression or availability compared to pain‐free controls.

Results

We identified 33 studies eligible for inclusion in the review, investigating 863 patients and 636 pain‐free controls. Three meta‐analyses of beta‐endorphin levels in blood and cerebrospinal fluid (CSF) were performed, revealing no significant differences between patients with FM or cLBP and controls. However, the grading of the evidence was very low. Mu‐opioid receptor (MOR) dysfunction emerged as a potential feature of FM, with some evidence suggesting reduced MOR binding in the brain and decreased MOR expression in immune cells.

Conclusions

Current evidence does not support altered peripheral endorphin levels in FM or cLBP, while emerging PET findings indicate reduced central MOR availability in FM. These results suggest receptor‐level dysregulation rather than peripheral opioid deficits. Limitations mainly arose from low sample sizes and inadequate study methodologies, underscoring the need for well‐designed studies with larger sample sizes to clarify the role of endogenous opioid dysfunction in FM and cLBP. Significance This systematic review highlights emerging evidence of mu‐opioid receptor dysfunction in fibromyalgia, despite no consistent differences in beta‐endorphin levels. The findings underscore significant methodological limitations in existing studies and point to the need for rigorous, well‐powered research to clarify the role of endogenous opioid dysregulation in chronic pain.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FibromyalgiaChronic PainReceptors, OpioidLow Back PainHumansBiomarkersbeta-EndorphinReceptors, Opioid, mu

Substanzen

Biomarkersbeta-EndorphinReceptors, Opioid, muReceptors, Opioid

Autor:innen und Institutionen

  • Pain Research Group, Pain Center, Odense University Hospital, Odense, Denmark.
  • Department of Clinical Research, Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark.
  • Pain Center Middelfart, Department of Anesthesiology, University Hospital of Southern Denmark, Vejle, Denmark.
  • Department of Regional Health Research, Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark.
  • Centre of Research in Patient Communication, Odense University Hospital, University of Southern Denmark, Odense, Denmark.
  • SimC, Simulation Centre, Odense University Hospital, Odense, Denmark.

ORCID-Profile: Karin Due Bruun, Maria Charlotte Reiersoel Moerkeberg, Julie Roenne Pedersen, Daniel Broholm, Morten Rune Blichfeldt-Eckhardt

Zitieren

APA

Bruun, K. D., Moerkeberg, M. C. R., Pedersen, J. R., Broholm, D., Blichfeldt-Eckhardt, M. R., & Abildgren, L. (2026). A Systematic Review With Meta‐Analysis of Endogenous Opioid System Biomarkers in Patients With Chronic Axial Pain, Chronic Widespread Pain, and Fibromyalgia. European Journal of Pain. https://doi.org/10.1002/ejp.70192

Vancouver

Bruun KD, Moerkeberg MCR, Pedersen JR, Broholm D, Blichfeldt-Eckhardt MR, Abildgren L. A Systematic Review With Meta‐Analysis of Endogenous Opioid System Biomarkers in Patients With Chronic Axial Pain, Chronic Widespread Pain, and Fibromyalgia. European Journal of Pain. 2026. doi:10.1002/ejp.70192

BibTeX
@article{Bruun2026,
  author = {Bruun, Karin Due and Moerkeberg, Maria Charlotte Reiersoel and Pedersen, Julie Roenne and Broholm, Daniel and Blichfeldt-Eckhardt, Morten Rune and Abildgren, Lotte},
  title = {A Systematic Review With Meta‐Analysis of Endogenous Opioid System Biomarkers in Patients With Chronic Axial Pain, Chronic Widespread Pain, and Fibromyalgia},
  journal = {European Journal of Pain},
  year = {2026},
  doi = {10.1002/ejp.70192}
}
Kostenlos starten →